Brain Tumors Clinical Practice Guidelines (2025)

Editorial Note: These are some of the highlights of the guidelines without analysis or commentary. For more information, go directly to the guidelines by clicking the link in the reference. Updated guidelines on therapy of adult diffuse astrocytic and oligodendroglial tumors were published in April 2025 by the American Society of Clinical Oncology and the … Read more

Iron Over Dopamine? Restless Legs Syndrome Guidelines Revamp

To reduce the risk for complications, the use of dopaminergic agonists in the treatment of severe restless legs syndrome (RLS) has become less common. RLS is characterized by an irresistible urge to move the legs, often accompanied by unpleasant sensations such as itching, tingling, or electric paresthesia, which typically affect the lower limbs. It affects … Read more

Canada Targets PCPs With New Hypertension Guideline

Hypertension Canada has released a guideline that aims to enhance the standard of hypertension management in primary care settings with evidence-based, pragmatic, and easy-to-implement recommendations. The guidance is based on the World Health Organization’s HEARTS framework to improve hypertension control and reduce cardiovascular burden. The previous guideline was published in 2020. “For the 2025 guideline, … Read more

Consider Spice Testing in Vulvar Dermatitis Complaints

TOPLINE: In patients with chronic vulvar complaints, allergic contact dermatitis (ACD) shows high prevalence with 86.6% exhibiting positive patch test reactions, of which 37.9% were clinically relevant. Nearly half of patients (43.3%) had reactions to spices and herbs, with 34.5% having clinically relevant reactions. METHODOLOGY: Researchers conducted a retrospective analysis of 67 adult patients with … Read more

Melanoma Adjuvant Therapy: OS Data Gaps Explained

BREAKING: Melanoma Adjuvant Therapy Faces Reimbursement Concerns The lack of definitive overall survival data for adjuvant therapy in stage III melanoma is prompting worries about reimbursement and treatment… The post Melanoma Adjuvant Therapy: OS Data Gaps Explained appeared first on NewsyList. Source link

Quick Turn to Mechanical Thrombectomy Improves PE Outcomes

Patients with pulmonary embolism (PE) who were treated with mechanical thrombectomy (MT) within 12 hours of hospital admission had significantly better pulmonary outcomes than patients treated with mechanical thrombectomy more than 12 hours after admission, based on new data from the FLASH registry. The benefits of prompt treatment with MT for patients with high-risk PE … Read more

Mixed Results for BC’s Opioid Standard for Noncancer Pain

An opioid prescribing practice standard for chronic noncancer pain (CNCP) was associated with accelerated declines in opioid doses and high-dose prescribing in British Columbia (BC) but also with more aggressive and inappropriate dose tapering, a new analysis showed. In addition, the standard resulted in restricted access to opioids for patients who may have benefited from … Read more

No Barrett’s Survival Benefit With Regular Surveillance

SAN DIEGO—Gastroenterologists have debated the best course of action for patients with Barrett’s esophagus for decades. Which is better for detecting early malignancy and preventing progression to esophageal adenocarcinoma (EAC) — surveillance endoscopy at regular intervals or only when symptoms occur? Does one offer a better chance of survival than the other? Now, researchers who … Read more

Emerging Biomarkers and Treatments in Anal Cancer

This transcript has been edited for clarity. Hello, my name is Van Morris. I’m a medical oncology physician at MD Anderson Cancer Center who takes care of patients with lower GI cancers. I’m excited to talk today about updates in anal cancer. Anal cancer is a rare cancer linked to prior infection with the human … Read more

Improved Treatment for Low-Grade PC Lesions

Archyde Expert Groups Advocate for Refined Approach to Diagnosing Indolent prostate Cancer May 8, 2025 Two leading international pathology societies are urging a shift in how indolent prostate cancers are detected and diagnosed, aiming to reduce overtreatment and improve patient outcomes. Teh Genitourinary Pathology Society (GUPS) and the International Society of Urological Pathology (ISUP) recently … Read more